{"organizations": [], "uuid": "81501df87b2f6fdaca071735e3fcaa7f7cfbd243", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180404.html", "section_title": "Archive News &amp; Video for Wednesday, 04 Apr 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-sofinnova-partners-launches-health/brief-sofinnova-partners-launches-healthcare-crossover-fund-with-275-mln-euros-idUSFWN1RG0WB", "country": "US", "domain_rank": 408, "title": "BRIEF-Sofinnova Partners launches healthcare crossover fund with 275 mln euros", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-04-04T13:20:00.000+03:00", "replies_count": 0, "uuid": "81501df87b2f6fdaca071735e3fcaa7f7cfbd243"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-sofinnova-partners-launches-health/brief-sofinnova-partners-launches-healthcare-crossover-fund-with-275-mln-euros-idUSFWN1RG0WB", "ord_in_thread": 0, "title": "BRIEF-Sofinnova Partners launches healthcare crossover fund with 275 mln euros", "locations": [], "entities": {"persons": [{"name": "sofinnova", "sentiment": "none"}], "locations": [{"name": "kck", "sentiment": "none"}, {"name": "asia", "sentiment": "none"}, {"name": "europe", "sentiment": "none"}], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "brief-sofinnova partners", "sentiment": "negative"}, {"name": "cnp", "sentiment": "none"}, {"name": "bpi france", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 4 (Reuters) - Sofinnova Partners:\n* Launches of Sofinnova Crossover I with €275 million ($340 million), above original first close target of €250 million\n* Sofinnova Crossover Fund I is the largest healthcare crossover fund focused on Europe\n* The fund will invest in the biopharmaceutical and medical device sectors\n* BPI France* and CNP Assurances acted as sponsors for the fund\n* Investors include a major Chinese biopharmaceutical company, the Danish State Investment fund, and family offices like Fidim or KCK representing leading industrial families in Europe and Asia, says Sofinnova\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-04-04T13:20:00.000+03:00", "crawled": "2018-04-05T17:07:32.021+03:00", "highlightTitle": ""}